Every discussion on advancing novel therapies brings us closer to a healthier world. Cell and Gene Meeting on the Med, April 16, 2025.

Our CEO @John W. Hadden II was honored to moderate this group of accomplished panelists.

@Hilary Eaton, PhD, Chief Business Officer @Profluent.bio
@Sadik Kassim, PhD, Chief Scientific Officer and Chief Technology Officer, Genomic Medicines Danaher Corporation

@Maryam Mokhtarzadeh, MD, Senior Director, Regulatory Strategy, @REGENXBIO

@Hilary Schultz, CEO and Founder, @Persephoni BioPartners

Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation at @Alliance for Regenerative Medicine’s 2025 Cell and Gene Meeting on the Med.

Contact us to discuss how our viral vector expertise can accelerate your therapy from lab to life.
virocell.com

#CGMed25 #cellandgenetherapy #CellandGeneTherapy #CellTherapy #GeneTherapy #advancedtherapies @Farzin Farzaneh, PhD @Nicholas Ostrout, Ph.D. @Traci Kyes
@Makis Sigalas, PhD